Literature DB >> 8879255

Frequent loss in chromosome 8p loci in liver cirrhosis accompanying hepatocellular carcinoma.

Y Kishimoto1, G Shiota, K Wada, M Kitano, K Nakamoto, Y Kamisaki, T Suou, T Itoh, H Kawasaki.   

Abstract

Most hepatocellular carcinoma (HCC) is preceded by liver cirrhosis, but the genetic changes involved in cirrhosis are not well understood. We therefore studied loss of heterozygosity (LOH) in cirrhotic and neoplastic foci in livers of 14 patients with HCC. The samples, microdissected from paraffin-embedded tissues, were analyzed using a polymerase-chain-reaction-based assay for dinucleotide repeat polymorphisms on 8p. Of the 14 cases, 13 showed constitutional heterozygosity for the microsatellite markers. In 7 (54%) of these 13 informative cases, LOH was detected in the primary HCC and, in these 7 doubly informative (informative and LOH-positive in primary HCC) cases, LOH was found in 16 (70%) of 23 liver cirrhotic foci. The pattern of 8p allelic loss was identical in each doubly informative tumor; however, some of the liver cirrhotic foci harbored an 8p loss identical to that seen in the primary HCC, some harbored a different 8p loss, and some did not harbor any 8p loss. The remaining 6 cases without LOH on 8p in HCC showed no 8p loss in any cirrhotic foci. Presumably HCC could develop from cirrhotic cells harboring 8p loss.

Entities:  

Mesh:

Year:  1996        PMID: 8879255     DOI: 10.1007/bf01221189

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  36 in total

1.  Flow cytometric analysis of the nuclear DNA content of hepatocellular carcinoma.

Authors:  H Ishizu
Journal:  Jpn J Surg       Date:  1989-11

Review 2.  Tumor suppressor genes.

Authors:  C J Marshall
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

3.  Loss of somatic heterozygosity in hepatocellular carcinoma.

Authors:  G J Walker; N K Hayward; S Falvey; W G Cooksley
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

4.  Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.

Authors:  M A Knowles; M E Shaw; A J Proctor
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

5.  Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.

Authors:  Y Murakami; K Hayashi; S Hirohashi; T Sekiya
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

6.  Molecular diagnosis of Prader-Willi syndrome: parent-of-origin dependent methylation sites and non-isotopic detection of (CA)n dinucleotide repeat polymorphisms.

Authors:  I Lerer; V Meiner; I Pashut-Lavon; D Abeliovich
Journal:  Am J Med Genet       Date:  1994-08-01

7.  p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.

Authors:  V Sundaresan; P Ganly; P Hasleton; R Rudd; G Sinha; N M Bleehen; P Rabbitts
Journal:  Oncogene       Date:  1992-10       Impact factor: 9.867

8.  Interstitial loss of the same region of 5q in multiple adenomas and a carcinoma derived from an adenomatous polyposis coli (APC) patient.

Authors:  Y Miki; I Nishisho; Y Miyoshi; J Utsunomiya; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

9.  Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma.

Authors:  N Nishida; Y Fukuda; H Kokuryu; T Sadamoto; G Isowa; K Honda; Y Yamaoka; M Ikenaga; H Imura; K Ishizaki
Journal:  Int J Cancer       Date:  1992-07-30       Impact factor: 7.396

10.  Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer.

Authors:  J A Macoska; T M Trybus; P D Benson; W A Sakr; D J Grignon; K D Wojno; T Pietruk; I J Powell
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

View more
  9 in total

1.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis.

Authors:  Yoshimasa Saito; Yae Kanai; Michiie Sakamoto; Hidetsugu Saito; Hiromasa Ishii; Setsuo Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-10       Impact factor: 11.205

2.  PinX1: a sought-after major tumor suppressor at human chromosome 8p23.

Authors:  Xiao Zhen Zhou
Journal:  Oncotarget       Date:  2011-10

3.  PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription.

Authors:  Hai-Long Li; Li Han; Hai-Rong Chen; Fei Meng; Qing-Hua Liu; Zhen-Qiang Pan; Jin Bai; Jun-Nian Zheng
Journal:  Oncotarget       Date:  2015-08-28

4.  PinX1 inhibits the invasion and metastasis of human breast cancer via suppressing NF-κB/MMP-9 signaling pathway.

Authors:  Meilin Shi; Menghan Cao; Jun Song; Qinghua Liu; Hailong Li; Fei Meng; Zhenqiang Pan; Jin Bai; Junnian Zheng
Journal:  Mol Cancer       Date:  2015-03-26       Impact factor: 27.401

Review 5.  PinX1: structure, regulation and its functions in cancer.

Authors:  Hai-Long Li; Jun Song; Hong-Mei Yong; Ping-Fu Hou; Yan-Su Chen; Wen-Bo Song; Jin Bai; Jun-Nian Zheng
Journal:  Oncotarget       Date:  2016-10-04

6.  Prognostic and Clinicopathological Value of PINX1 in Various Human Tumors: A Meta-Analysis.

Authors:  Hao Liang; Zhiyong Xiong; Ying Li; Weihao Kong; Zhicheng Yao; Ruixi Li; Meihai Deng; Kunpeng Hu
Journal:  Biomed Res Int       Date:  2018-07-16       Impact factor: 3.411

7.  The pattern of gene copy number alteration (CNAs) in hepatocellular carcinoma: an in silico analysis.

Authors:  Arman Shahrisa; Maryam Tahmasebi-Birgani; Hossein Ansari; Zahra Mohammadi; Vinicio Carloni; Javad Mohammadi Asl
Journal:  Mol Cytogenet       Date:  2021-07-02       Impact factor: 2.009

8.  PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.

Authors:  Jian-Ye Liu; Dong Qian; Li-Ru He; Yong-Hong Li; Yi-Ji Liao; Shi-Juan Mai; Xiao-Peng Tian; Yan-Hui Liu; Jia-Xing Zhang; Hsiang-Fu Kung; Yi-Xin Zeng; Fang-Jian Zhou; Dan Xie
Journal:  Mol Cancer       Date:  2013-11-23       Impact factor: 27.401

9.  Association between the PINX1 and NAT2 polymorphisms and serum lipid levels.

Authors:  Qing-Hui Zhang; Rui-Xing Yin; Feng Huang; De-Zhai Yang; Wei-Xiong Lin; Shang-Ling Pan
Journal:  Oncotarget       Date:  2017-12-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.